NSRX (NASUS PHARMA LTD) is held by 5 institutional investors as of Q1 2026. Largest holders: BALYASNY ASSET MANAGEMENT L.P. ($2M), Hudson Bay Capital Management LP ($299,192), UBS Group AG ($6,869). Net institutional sentiment: Bullish.
See how NSRX's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer